Aaron I. Davis Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Aaron I. Davis.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Aaron I. Davis. Aaron I. Davis is a in Mirati Therapeutics, Inc. ($MYG) and a Director in Mirati Therapeutics, Inc. ($MYG) and a Director in Odonate Therapeutics, Inc. ($ODT) and a Director in Rain Therapeutics Inc. ($RAIN) and a Director in iTeos Therapeutics, Inc. ($ITOS).
Address: 440 STEVENS AVE, SUITE 100 SOLANA BEACH 92075 CA
Companies in which Aaron I. Davis is an Insider
iTeos Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Aaron I. Davis: Director
Holdings: 2,943,568 shares
Latest Transaction: Jul 30 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Mirati Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Aaron I. Davis:
Holdings: 40,527 shares
Latest Transaction: Jan 20 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Odonate Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Aaron I. Davis: Director
Holdings: 5,282,086 shares
Latest Transaction: Dec 30 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Rain Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Aaron I. Davis: Director
Holdings: 25,000 shares
Latest Transaction: Apr 27 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Aaron I. Davis
Sentiment: All, ITOS, MYG, ODT, RAIN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 2021 | RAIN | Rain Therapeutics ... | Davis Aaron I. | Director | Option Exercise | C | 0.00 | 79,726 | 0 | 79,726 | |
| Apr 27 2021 | RAIN | Rain Therapeutics ... | Davis Aaron I. | Director | Option Exercise | C | 0.00 | 3,022,489 | 0 | 3,022,489 | |
| Apr 27 2021 | RAIN | Rain Therapeutics ... | Davis Aaron I. | Director | Option Exercise | C | 0.00 | 86,097 | 0 | 0 | |
| Apr 27 2021 | RAIN | Rain Therapeutics ... | Davis Aaron I. | Director | Option Exercise | C | 0.00 | 3,263,986 | 0 | 0 | |
| Apr 27 2021 | RAIN | Rain Therapeutics ... | Davis Aaron I. | Director | Buy | P | 17.00 | 1,025,000 | 17,425,000 | 1,175,000 | 150 K to 1.2 M (+683.33 %) |
| Apr 27 2021 | RAIN | Rain Therapeutics ... | Davis Aaron I. | Director | Buy | P | 16.27 | 125,000 | 2,033,750 | 150,000 | 25 K to 150 K (+500.00 %) |
| Apr 27 2021 | RAIN | Rain Therapeutics ... | Davis Aaron I. | Director | Buy | P | 15.58 | 25,000 | 389,500 | 25,000 | 0 to 25 K |